Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences

DALLAS--(BUSINESS WIRE)-- Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, will be presenting at 3 upcoming healthcare conferences.

Forte will be presenting at the Guggenheim 2nd Annual Healthcare Innovation Conference at the InterContinental Boston in Boston MA on Mon, Nov 10 at 3:30-3:55 PM ET.

On Nov. 12 at 2:00-2:20 PM ET, Forte will present at the virtual TD Cowen Immunology and Inflammation Summit.

Additionally on Dec 4 at 11:15-11:35 AM ET, Forte will be presenting at the 8th Annual Evercore Healthcare Conference in Coral Gables FL at the Loews Hotel.

Source: Forte Biosciences, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251103872383/en/

LifeSci Advisors
Mike Moyer, Managing Director
[email protected]

Forte Biosciences, Inc.
Paul Wagner, CEO
[email protected]

Source: Forte Biosciences, Inc.

You May Also Be Interested In

• Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting
• Virtus Convertible & Income Fund Announces Quarterly Distribution: 5.625% Series A Cumulative Preferred Shares
• Virtus Dividend, Interest & Premium Strategy Fund Announces Distribution and Discloses Sources of Distribution – Section 19(a) Notice